Belvederi MurriM, GuaglianoneA, BuglianiM, et al.Second-generation antipsychotics and neuroleptic malignant syndrome: Systematic review and case report analysis. Drugs R D, 2015; 15(1):45–62; doi: 10.1007/s40268-014-0078-0
2.
JallaqSA, VerbaM, StrawnJR, et al.CYP2D6 phenotype influences aripiprazole tolerability in pediatric patients with mood disorders. J Child Adolesc Psychopharmacol, 2021; 31(1):56–62; doi: 10.1089/cap.2020.0058
3.
PrakashS, LodhaD, RawatKS. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: Does it exist? BMJ Case Reports, 2021; 14(8):e241578; doi: 10.1136/bcr-2021-241578
